TOKYO,Jan. 10,2025 --TIER IV,the pioneering force behind the world's first open-source software for autonomous driving,has secured a permit for Level 4 operations in Shiojiri,Nagano Prefecture. This milestone was realized in collaboration with the local government and service operators.
Since 2020,TIER IV and its partners have been conducting proof of concept tests aimed at establishing mobility services enabled by autonomous driving technology. In October 2024,TIER IV received Level 4 certification under the Road Transport Vehicle Act. The newly obtained permit,issued under the Road Traffic Act,allows the deployment of a Level 4 autonomous driving system that independently manages all dynamic driving tasks under predefined conditions.
The upcoming tests will employ TIER IV's Minibus,which will operate on public roads shared with both pedestrians and general traffic,specifically running between Shiojiri Station and Shiojiri City Hall.
TIER IV is committed to addressing regional transportation challenges,including driver shortages,by leveraging its growing track record of Level 4 autonomous driving operations in Shiojiri and paving the way for the future implementation of autonomous driving services.
About TIER IV
TIER IVstands at the forefront of deep tech innovation,pioneering Autoware,the world's first open-source software for autonomous driving. Harnessing Autoware,we build scalable platforms and deliver comprehensive solutions across software development,vehicle manufacturing,and service operations. As a founding member of the Autoware Foundation,we are committed to reshaping the future of intelligent vehicles with open-source software,enabling individuals and organizations to thrive in the evolving field of autonomous driving.
Autoware is a registered trademark of the Autoware Foundation.
Media Contact
Business Inquires
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
Mar 18, 2025
The global fashion powerhouse brought bold style and interactive experiences to the world\'s biggest hip-hop festival
Mar 18, 2025
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
Mar 18, 2025
Strengthening Asia\'s Position in the Global Wealth and Investment Landscape MACAO,March 17,2025-- BEYOND Expo,Asia\'s premier platform for technology and innovation,is proud to announce the BEYOND We
Mar 18, 2025